Effect of the phytotherapeutic agent eviprostat on inflammatory changes and cytokine production in a rat model of nonbacterial prostatitis

Urology

Volumn 77, Issue 6, 2011, Pages 1507.e15-1507.e20

  Tsunemori, Hiroyuki ^a,b   Sugimoto, Mikio ^a,b   Xia, Zhang ^a,b   Taoka, Rikiya ^a,b   Oka, Michiko ^a,b   Kakehi, Yoshiyuki ^a,b  

^a KAGAWA UNIVERSITY   (Japan)

^b NIPPON SHINYAKU CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; EVIPROSTAT; GROWTH DIFFERENTIATION FACTOR 15; INTERLEUKIN 8; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATITIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA; UPREGULATION;

EID: 79957881251     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2011.02.017     Document Type: Article

References (16)

1. McVary KT. BPH: epidemiology and comorbidities. Am J Manag Care. 2006;12:S122-S128.
2. Nickel JC. Prostatic inflammation in benign prostatic hyperplasia - the third component? Can J Urol. 1994;1:1-4.
3. McConnell JD, Roehrborn CG, Bautista OM, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349:2387-2398. (Pubitemid 37542987)
4. Prakash K, Pirozzi G, Elashoff M, et al. Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays. Proc Natl Acad Sci U S A. 2002;99:7598-7603. (Pubitemid 34568737)
5. Bootcov MR, Bauskin AR, Valenzuela SM, et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A. 1997;94:11514-11519. (Pubitemid 27451030)
6. Taoka R, Tsukuda F, Ishikawa M, Haba R, Kakehi Y. Association of prostatic inflammation with down-regulation of macrophage inhibitory cytokine-1 gene in symptomatic benign prostatic hyperplasia. J Urol. 2004;171:2330-2335. (Pubitemid 38625464)
7. Kamijo T, Sato S, Kitamura T. Effect of cernitin pollen-extract on experimental nonbacterial prostatitis in rats. Prostate. 2001;49:122-131. (Pubitemid 32937808)
8. Taniguchi S, Taoka R, Inui M, Sugimoto M, Kakehi Y. Influence of inflammation and aging on macrophage inhibitory cytokine-1 gene expression in rat ventral prostate. Urology. 2009;73:410-414.
9. Oka M, Ueda M, Oyama T, Kyotani J, Tanaka M. Effect of the phytotherapeutic agent eviprostat on 17beta-estradiol-induced nonbacterial inflammation in the rat prostate. Prostate. 2009;69:1404-1410.
10. Oka M, Tachibana M, Noda K, et al. Relevance of anti-reactive oxygen species activity to anti-inflammatory activity of components of eviprostat, a phytotherapeutic agent for benign prostatic hyperplasia. Phytomedicine. 2007;14:465-472. (Pubitemid 47068955)
11. Liu L, Li Q, Han P, et al. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia. Urology. 2009;74:340-344.
12. Tagaya M, Oka M, Ueda M, et al. Eviprostat suppresses proinflammatory gene expression in the prostate of rats with partial bladderoutlet obstruction: a genome-wide DNA microarray analysis. Cytokines. 2009;47:185-193.
13. Hochreiter WW, Nadler RB, Koch AE, et al. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology. 2000;56:1025-1029.
14. Penna G, Mondaini N, Amuchastegui S, et al. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia. Eur Urol. 2007;51:524-533; [Discussion: 533].
15. Kramer G, Mitteregger D, Marberger M. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol. 2007;51: 1202-1216.
16. Wagenlehner FM, Schneider H, Ludwig M, et al. A pollen extract (cernilton) in patients with inflammatory chronic prostatitischronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study. Eur Urol. 2009;56:544-551.